Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

March 21, 2006

Primary Completion Date

August 1, 2007

Study Completion Date

August 20, 2007

Conditions
Chronic Insomnia
Interventions
DRUG

Ramelteon

Ramelteon 8mg, tablets, orally, once nightly for up to 8 weeks.

DRUG

Placebo

Ramelteon placebo matching tablets, orally, once nightly for up to 8 weeks.

Trial Locations (72)

Unknown

Alabaster

Huntsville

Phoenix

Sun City

Tucson

Costa Mesa

Fresno

Irvine

Los Angeles

National City

Oxnard

San Diego

San Francisco

Darien

Waterbury

Boynton Beach

Bradenton

Brooksville

Deerfield Beach

Fort Myers

Hallandale

Hialeah

Hollywood

Largo

Miami

Naples

Orange City

Pompano Beach

Port Charlotte

Sarasota

Sunrise

Tampa

West Palm Beach

Atlanta

Savannah

Honolulu

Chicago

Indianapolis

Lexington

Boston

West Yarmouth

Grand Rapids

St Louis

Las Vegas

Dover

Piscataway

Princeton

Stratford

Toms River

Whiting

Albuquerque

Brooklyn

New Hyde Park

New York

Cincinnati

Columbus

Oklahoma City

Eugene

Havertown

Jenkintown

Moon Township

Philadelphia

Beaufort

Greer

North Charleston

Bellaire

Houston

San Antonio

Wichita Falls

Bennington

Burlington

Middleton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY